Home Markets Q32 Bio: Oppenheimer slashes price target on mixed trial results Q32 Bio: Oppenheimer slashes price target on mixed trial results Andrew M Dec 11, 2024 comments off Tweet on Twitter Share on Facebook Google+ Pinterest Original source: https://www.investing.com/news/stock-market-news/q32-bio-oppenheimer-slashes-price-target–on-mixed-trial-results-3765273 Bio Therapeutic Drugs Market Updates Q32 BIO www.investing.com/news/stock-market-news/q32-bio-oppenheimer-slashes-price-target--on-mixed-trial-results-3765273